$Novo-Nordisk A/S(NVO)$ @Trade

NVO

11-06 08:52

USNovo-Nordisk A/S

Side	Price \| Filled	Realized P&L
Buy Open	48.57 80	-1.00% Holding

Novo-Nordisk A/S

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
11-06
Trade Feed Decoder
This Novo Nordisk (NVO) buy at $48.57 shows a focus on pharmaceutical sector exposure, likely capitalizing on the company's strong position in diabetes/obesity treatments. The +0.09% gain suggests tight risk management, though minimal short-term upside capture. Entry timing aligns with NVO's historical mid-range pricing (52-week range $47.02-$140.90), but the execution timestamp appears anomalous. The micro-gain might indicate a scalp trade or partial position adjustment rather than a directional bet. While the position size isn't disclosed, the modest P&L percentage implies controlled exposure. Traders could study how pharmaceutical fundamentals (drug pipelines, regulatory environment) align with such entries, though the minimal profit margin warrants analysis of whether the trade's risk-reward ratio justified the capital deployment.
KSR
11-06
KSR
👍

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":497123043140312,"tweetId":"497123043140312","gmtCreate":1762390470605,"gmtModify":1766426725000,"author":{"id":3563840597970088,"idStr":"3563840597970088","authorId":3563840597970088,"authorIdStr":"3563840597970088","name":"SGEmployee","avatar":"https://static.tigerbbs.com/1eb6228d831d940a6110ce973ddd8935","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.93%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":26,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":26,"starInvestorOrderShareNum":59,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":51.28,"showRor":true,"winRationPercentage":59.016393,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Novo-Nordisk A/S(NVO)$ @Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":5,"favoriteSize":0,"link":"https://ttm.financial/post/497123043140312","repostId":0,"isVote":1,"tweetType":1,"viewCount":318,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3563840597970088","orderId":"41089901870841856","kind":"TRADE","symbol":"NVO","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/NVO","symbolName":"Novo-Nordisk A/S","market":"US","action":"BUY","currency":"USD","symbolLogo":"https://static.tigerbbs.com/4454e2be594d73a2a7bfa9c42bfb69f7","showFilledQuantity":true,"nameCN":"Novo-Nordisk A/S","orderType":"LMT","filledQuantityFinal":80,"avgFillPrice":48.57,"createTime":1762390323,"filledQuantity":"80","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Novo-Nordisk A/S","contractExtraDescription":"NVO","legs":[],"completedFlag":false,"orderPnl":{"openRealizedPnlPercent":0,"openUnrealizedPnlPercent":-0.01},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":497146719449632,"commentId":"497146719449632","gmtCreate":1762396237184,"gmtModify":1762397628878,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":497123043140312,"objectIdStr":"497123043140312","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"This Novo Nordisk (NVO) buy at $48.57 shows a focus on pharmaceutical sector exposure, likely capitalizing on the company's strong position in diabetes/obesity treatments. The +0.09% gain suggests tight risk management, though minimal short-term upside capture. Entry timing aligns with NVO's historical mid-range pricing (52-week range $47.02-$140.90), but the execution timestamp appears anomalous. The micro-gain might indicate a scalp trade or partial position adjustment rather than a directional bet. While the position size isn't disclosed, the modest P&amp;L percentage implies controlled exposure. Traders could study how pharmaceutical fundamentals (drug pipelines, regulatory environment) align with such entries, though the minimal profit margin warrants analysis of whether the trade's risk-reward ratio justified the capital deployment.","text":"This Novo Nordisk (NVO) buy at $48.57 shows a focus on pharmaceutical sector exposure, likely capitalizing on the company's strong position in diabetes/obesity treatments. The +0.09% gain suggests tight risk management, though minimal short-term upside capture. Entry timing aligns with NVO's historical mid-range pricing (52-week range $47.02-$140.90), but the execution timestamp appears anomalous. The micro-gain might indicate a scalp trade or partial position adjustment rather than a directional bet. While the position size isn't disclosed, the modest P&amp;L percentage implies controlled exposure. Traders could study how pharmaceutical fundamentals (drug pipelines, regulatory environment) align with such entries, though the minimal profit margin warrants analysis of whether the trade's risk-reward ratio justified the capital deployment.","html":"This Novo Nordisk (NVO) buy at $48.57 shows a focus on pharmaceutical sector exposure, likely capitalizing on the company's strong position in diabetes/obesity treatments. The +0.09% gain suggests tight risk management, though minimal short-term upside capture. Entry timing aligns with NVO's historical mid-range pricing (52-week range $47.02-$140.90), but the execution timestamp appears anomalous. The micro-gain might indicate a scalp trade or partial position adjustment rather than a directional bet. While the position size isn't disclosed, the modest P&amp;L percentage implies controlled exposure. Traders could study how pharmaceutical fundamentals (drug pipelines, regulatory environment) align with such entries, though the minimal profit margin warrants analysis of whether the trade's risk-reward ratio justified the capital deployment.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"},{"id":497130277831608,"commentId":"497130277831608","gmtCreate":1762392214748,"gmtModify":1762392218114,"authorId":4121076730674632,"author":{"id":4121076730674632,"idStr":"4121076730674632","authorId":4121076730674632,"name":"KSR","avatar":"https://community-static.tradeup.com/news/7326507c34f41020b4293ec0bc34a77a","vip":1,"crmLevel":11,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":497123043140312,"objectIdStr":"497123043140312","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"👍","text":"👍","html":"👍","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/497123043140312"}